HEARTPrep: A Virtually-delivered Psychosocial Intervention for Mothers Expecting a Baby With Congenital Heart Disease
Key facts
- Who runs it
- Nemours Children's Clinic
- Where
- Wilmington, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 14 Jul 2023
- Ended
- 31 May 2025
- Type of study
- Interventional
- Treatments tested
- HEARTPrep
- Record updated
- 31 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Expectant mothers carrying a fetus with congenital heart disease expected to require cardiac surgery in the first year of life
- Partners of participating expectant mothers can also participate together with the mother
- Receiving fetal cardiac care at Nemours Children's Health
- Speaks English or Spanish fluently
- Age 18 or older
- Access to a computer, tablet or mobile device with internet access
Who cannot take part
- -Fetus has a genetic syndrome or other comorbid condition associated with a life expectancy of less than one year
Where in United States
- Nemours Children's HealthWilmington, United States
About the trial
What the trial wants to find out
Congenital heart disease (CHD) is the most common birth defect and is increasingly diagnosed prenatally. Mothers describe their prenatal experiences as highly stressful and traumatic after a diagnosis of CHD. Maternal stress during pregnancy exerts a powerful influence on birth outcomes and developmental trajectories, particularly for children in underserved populations. In partnership with diverse parent and clinician stakeholders, our team designed HEARTPrep, an innovative, virtually-delivered psychosocial intervention for mothers expecting a baby with CHD. This project will pilot HEARTPrep with mothers expecting a baby with CHD to obtain preliminary data for a larger future trial. This intervention has the potential to improve emotional wellbeing in mothers expecting a baby with CHD, thereby altering developmental trajectories for this large population of children.
The group in the trial
- HEARTPrepTreatment being tested
HEARTPrep is a virtually-delivered psychosocial intervention for mothers expecting a baby with CHD. HEARTPrep consists of three distinct modules: Adjusting, Connecting, and Preparing. Each module targets one distinct primary outcome (emotional distress, social isolation, parenting self-efficacy) and a common secondary outcome (hope) through a suite of evidence-based intervention elements (e.g., psychoeducation, cognitive restructuring, mindfulness) for addressing emotional problems in other populations, including pregnant women. HEARTPrep elements include: a) telehealth with a psychosocial provider, b) recorded videos, c) educational tools, and d) links to resources.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 31 August 2026